Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2023-10-24 00:00:00 ET · period of report 2023-10-22 · accession 0001628280-23-035026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-24 | 2023-10-22 | BLFS | Mathew Aby J. | EVP, CSO | A - Grant | — | +1,034 | 274.9K | +0.4% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-22 | A | A | 1,034 | — | 274,934 | D | — | — | (F1) The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. |